 |
PDBsum entry 1cnn
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
289:1405-1421
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure-activity relationships of omega-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N and P/Q-type calcium channels.
|
|
K.J.Nielsen,
D.Adams,
L.Thomas,
T.Bond,
P.F.Alewood,
D.J.Craik,
R.J.Lewis.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The omega-conotoxins are a set of structurally related, four-loop, six cysteine
containing peptides, that have a range of selectivities for different subtypes
of the voltage-sensitive calcium channel (VSCC). To investigate the basis of the
selectivity displayed by these peptides, we have studied the binding affinities
of two naturally occurring omega-conotoxins, MVIIA and MVIIC and a series of 14
MVIIA/MVIIC loop hybrids using radioligand binding assays for N and P/Q-type
Ca2+channels in rat brain tissue. A selectivity profile was developed from the
ratio of relative potencies at N-type VSCCs (using [125I]GVIA radioligand
binding assays) and P/Q-type VSCCs (using [125I]MVIIC radioligand binding
assays). In these peptides, loops 2 and 4 make the greatest contribution to VSCC
subtype selectivity, while the effects of loops 1 and 3 are negligible. Peptides
with homogenous combinations of loop 2 and 4 display clear selectivity
preferences, while those with heterogeneous combinations of loops 2 and 4 are
less discriminatory. 1H NMR spectroscopy revealed that the global folds of
MVIIA, MVIIC and the 14 loop hybrid peptides were similar; however, several
differences in local structure were identified. Based on the binding data and
the 3D structures of MVIIA, GVIA and MVIIC, we have developed a preliminary
pharmacophore based on the omega-conotoxin residues most likely to interact with
the N-type VSCC.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 7.
Figure 7. Profiles of (a) relative selectivity shown in rank
order and (b) absolute potency shown in rank order within the
four groups defined in (a), namely XCXC, XCXA, XAXC and XAXA.
|
 |
Figure 9.
Figure 9. (a) Solid surface (1.4 Å radius) of six
residues likely to be involved in N-type VSCC binding
interactions. These are numbered according to (1) Tyr13 (from
MVIIA), (2) Arg10 (MVIIA), (3) Leu11 (MVIIA), (4) Arg21 (MVIIA),
(5) Tyr22 (GVIA), and (6) Lys24 (GVIA). The backbone of MVIIA
(pink) is shown in correct orientation for binding. In (b), (c)
and (d) the same surface as in (a) is shown, but in dot format.
Inside this surface is shown the heavy atoms of (b) MVIIA, (c)
GVIA (backbone blue), and (d) MVIIC (backbone purple). The
side-chains are color-coded in the following manner: yellow
(hydrophobic), green (polar), red (negative) and blue
(positive). Binding surfaces which are optimally filled are
labeled in pink. Residues that form a possible clash (negative
interaction) are denoted in red (site 5 and R9 of MVIIC).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1999,
289,
1405-1421)
copyright 1999.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.I.Schroeder,
J.Ekberg,
K.J.Nielsen,
D.Adams,
M.L.Loughnan,
L.Thomas,
D.J.Adams,
P.F.Alewood,
and
R.J.Lewis
(2008).
Neuronally micro-conotoxins from Conus striatus utilize an alpha-helical motif to target mammalian sodium channels.
|
| |
J Biol Chem,
283,
21621-21628.
|
 |
|
|
|
|
 |
J.G.McGivern
(2007).
Ziconotide: a review of its pharmacology and use in the treatment of pain.
|
| |
Neuropsychiatr Dis Treat,
3,
69-85.
|
 |
|
|
|
|
 |
U.C.Marx,
N.L.Daly,
and
D.J.Craik
(2006).
NMR of conotoxins: structural features and an analysis of chemical shifts of post-translationally modified amino acids.
|
| |
Magn Reson Chem,
44,
S41-S50.
|
 |
|
|
|
|
 |
L.Wen,
S.Yang,
H.Qiao,
Z.Liu,
W.Zhou,
Y.Zhang,
and
P.Huang
(2005).
SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons.
|
| |
Br J Pharmacol,
145,
728-739.
|
 |
|
|
|
|
 |
C.Bernard,
G.Corzo,
S.Adachi-Akahane,
G.Foures,
K.Kanemaru,
Y.Furukawa,
T.Nakajima,
and
H.Darbon
(2004).
Solution structure of ADO1, a toxin extracted from the saliva of the assassin bug, Agriosphodrus dohrni.
|
| |
Proteins,
54,
195-205.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Mould,
T.Yasuda,
C.I.Schroeder,
A.M.Beedle,
C.J.Doering,
G.W.Zamponi,
D.J.Adams,
and
R.J.Lewis
(2004).
The alpha2delta auxiliary subunit reduces affinity of omega-conotoxins for recombinant N-type (Cav2.2) calcium channels.
|
| |
J Biol Chem,
279,
34705-34714.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.J.Adams,
A.B.Smith,
C.I.Schroeder,
T.Yasuda,
and
R.J.Lewis
(2003).
Omega-conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals.
|
| |
J Biol Chem,
278,
4057-4062.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.A.Sharpe,
L.Thomas,
M.Loughnan,
L.Motin,
E.Palant,
D.E.Croker,
D.Alewood,
S.Chen,
R.M.Graham,
P.F.Alewood,
D.J.Adams,
and
R.J.Lewis
(2003).
Allosteric alpha 1-adrenoreceptor antagonism by the conopeptide rho-TIA.
|
| |
J Biol Chem,
278,
34451-34457.
|
 |
|
|
|
|
 |
K.J.Nielsen,
M.Watson,
D.J.Adams,
A.K.Hammarström,
P.W.Gage,
J.M.Hill,
D.J.Craik,
L.Thomas,
D.Adams,
P.F.Alewood,
and
R.J.Lewis
(2002).
Solution structure of mu-conotoxin PIIIA, a preferential inhibitor of persistent tetrodotoxin-sensitive sodium channels.
|
| |
J Biol Chem,
277,
27247-27255.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Melena,
G.Chidlow,
and
N.N.Osborne
(2000).
Blockade of voltage-sensitive Na(+) channels by the 5-HT(1A) receptor agonist 8-OH-DPAT: possible significance for neuroprotection.
|
| |
Eur J Pharmacol,
406,
319-324.
|
 |
|
|
|
|
 |
K.J.Nielsen,
T.Schroeder,
and
R.Lewis
(2000).
Structure-activity relationships of omega-conotoxins at N-type voltage-sensitive calcium channels.
|
| |
J Mol Recognit,
13,
55-70.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |